Barclays’s Argos Therapeutics, Inc. ARGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1
| Closed | – | – | 4652 |
|
|
2018
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4619 |
|
|
2017
Q4 | – | Sell |
-5
| Closed | – | – | 4380 |
|
|
2017
Q3 | $0 | Sell |
5
-328
| -98% | – | ﹤0.01% | 4331 |
|
|
2017
Q2 | $2K | Buy |
333
+295
| +776% | +$1.77K | ﹤0.01% | 3737 |
|
|
2017
Q1 | $0 | Buy |
38
+20
| +111% | – | ﹤0.01% | 4338 |
|
|
2016
Q4 | $2K | Buy |
18
+9
| +100% | +$1K | ﹤0.01% | 3674 |
|
|
2016
Q3 | $1K | Sell |
9
-156
| -95% | -$17.3K | ﹤0.01% | 3907 |
|
|
2016
Q2 | $20K | Buy |
+165
| New | +$20K | ﹤0.01% | 2823 |
|
|
2014
Q4 | – | Sell |
-3
| Closed | -$1K | – | 4621 |
|
|
2014
Q3 | $1K | Sell |
3
-299
| -99% | -$99.7K | ﹤0.01% | 4315 |
|
|
2014
Q2 | $48K | Buy |
302
+296
| +4,933% | +$47K | ﹤0.01% | 3065 |
|
|
2014
Q1 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 4266 |
|